Markets

Aviv REIT prices IPO at $20 high end, raising $264 million

Aviv REIT, which specializes in post-acute and long-term care skilled nursing facilities, raised $264 million by offering 13.2 million shares at $20, the high end of the range of $18 to $20. Aviv REIT, which initially filed confidentially on 10/31/2012, plans to list on the NYSE under the symbol "AVIV". Morgan Stanley, BofA Merrill Lynch and Goldman Sachs acted as lead managers on the deal.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

IPOs

Latest Markets Videos

Renaissance Capital

Renaissance Capital is the global leader in providing pre-IPO institutional research and management of IPO-focused investment products.

Learn More